​
Login / Signup
Kathleen Kong
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 2
Top Topics
Epidermal Growth Factor Receptor
Clinical Trial
Metastatic Breast Cancer
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Timothy P DiPeri
,
Kathleen Kong
,
Kaushik Varadarajan
,
Daniel D Karp
,
Jaffer A Ajani
,
Shubham Pant
,
Michael F Press
,
Sarina A Piha-Paul
,
Ecaterina E Ileana Dumbrava
,
Funda Meric-Bernstam
Discordance of HER2 Expression and/or Amplification on Repeat Testing.
Molecular cancer therapeutics
(2023)
Timothy P DiPeri
,
Kurt W Evans
,
Maria Gabriela Raso
,
Ming Zhao
,
Yasmeen Q Rizvi
,
Xiaofeng Zheng
,
Bailiang Wang
,
Bryce P Kirby
,
Kathleen Kong
,
Michael Kahle
,
Timothy Anthony Yap
,
Ecaterina E Ileana Dumbrava
,
Jaffer A Ajani
,
Siqing Fu
,
Khandan Keyomarsi
,
Funda Meric-Bernstam
Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)